Exclusive Distribution in Japan of Penumbra's Peripheral Vascular Thrombectomy Device
First written in FY2023-Q1. 2 of 3 entries say "Restated". Latest entry: FY2023-Q3.
No other company in this theme has enough history to compare yet.
- FY2023-Q3RestatedAnnual report
「① Entered into a basic agreement for the exclusive distribution in the Japanese market of Penumbra Inc. (US) thrombectomy devices for peripheral blood vessels」
The basic agreement for the exclusive distribution in Japan of Penumbra’s thrombectomy devices for peripheral blood vessels is being reaffirmed. - FY2023-Q2RestatedAnnual report
「As an initiative toward achieving this, during the cumulative second quarter consolidated period the company entered into a basic agreement for the exclusive distribution in the Japanese market of Penumbra Inc. (US) thrombectomy devices for peripheral blood vessels.」
The basic agreement for the exclusive distribution in Japan of Penumbra’s thrombectomy devices for peripheral blood vessels is being reaffirmed. - FY2023-Q1First statedAnnual report
「As an initiative toward achieving this, during the cumulative first quarter consolidated period the company entered into a basic agreement for the exclusive distribution in the Japanese market of Penumbra Inc. (US) thrombectomy devices for peripheral blood vessels.」
The company entered into a basic agreement for the exclusive distribution in the Japanese market of Penumbra Inc.’s thrombectomy devices for peripheral blood vessels.